Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2014

01.04.2014 | Epidemiology

Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer

verfasst von: Timothy L. Lash, Soe Soe Thwin, Marianne Ulcickas Yood, Ann M. Geiger, Jaclyn Bosco, Virginia P. Quinn, Terry S. Field, Pamala A. Pawloski, Rebecca A. Silliman

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Late effects of breast cancer affect the quality of survivorship. Using administrative data, we compared the occurrence of almost all ICD9 codes among older breast cancer survivors to that among a matched comparison cohort to generate new hypotheses. Breast cancer patients 65 years or older diagnosed 1990–1994 in 6 integrated care settings and who survived at least 5 years were matched with a cohort of women without a history of breast cancer on care setting, age, and calendar time. We collected data on the occurrence of incident ICD9 codes beginning 6 years after the breast cancer diagnosis date and continuing to year 15, and comparable data for the matched woman. We calculated hazard ratios (HRs) and 95 % confidence intervals associating breast cancer survivorship with incidence of each ICD9 code. We used semi-Bayes methods to address multiple comparisons. Older breast cancer survivors had about the same occurrence of diseases and conditions 6–15 years after breast cancer diagnosis as comparable women. The median of 564 adjusted HRs equaled 1.06, with interquartile range 0.92–1.3. The distribution of HRs pertaining to cancer-related ICD codes was shifted toward positive associations, and the distribution pertaining to cardiovascular-related ICD codes was shifted toward negative associations. In this hypothesis-scanning study, we observed little difference in the occurrence of non-breast cancer-related diseases and conditions among older, long-term breast cancer survivors, and comparable women without a history of breast cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99(5):365–375. doi:10.1093/jnci/djk064 PubMedCrossRef Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99(5):365–375. doi:10.​1093/​jnci/​djk064 PubMedCrossRef
4.
7.
Zurück zum Zitat Lash TL, Silliman RA (2002) Long-term follow-up of upper-body function among breast cancer survivors. Breast J 8(1):28–33PubMedCrossRef Lash TL, Silliman RA (2002) Long-term follow-up of upper-body function among breast cancer survivors. Breast J 8(1):28–33PubMedCrossRef
8.
Zurück zum Zitat Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033. doi:10.1200/JCO.2003.08.097 PubMedCrossRef Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21(21):4027–4033. doi:10.​1200/​JCO.​2003.​08.​097 PubMedCrossRef
9.
Zurück zum Zitat Raj KA, Marks LB, Prosnitz RG (2005) Late effects of breast radiotherapy in young women. Breast Dis 23:53–65PubMed Raj KA, Marks LB, Prosnitz RG (2005) Late effects of breast radiotherapy in young women. Breast Dis 23:53–65PubMed
10.
Zurück zum Zitat de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB (2012) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33(12):2971–2983. doi:10.1002/hbm.21422 PubMedCrossRef de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB (2012) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33(12):2971–2983. doi:10.​1002/​hbm.​21422 PubMedCrossRef
12.
Zurück zum Zitat Herrmann T, Gunther C, Csere P (2009) Localized morphea–a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 185 (9):603–607. doi:10.1007/s00066-009-2051-3 Herrmann T, Gunther C, Csere P (2009) Localized morphea–a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 185 (9):603–607. doi:10.​1007/​s00066-009-2051-3
13.
Zurück zum Zitat Canzler U, Schmidt-Gohrich UK, Bergmann S, Hanseroth K, Gatzweiler A, Distler W (2007) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by vinorelbine treatment of metastatic breast cancer. Onkologie 30(8–9):455–456. doi:10.1159/0000105143 PubMedCrossRef Canzler U, Schmidt-Gohrich UK, Bergmann S, Hanseroth K, Gatzweiler A, Distler W (2007) Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by vinorelbine treatment of metastatic breast cancer. Onkologie 30(8–9):455–456. doi:10.​1159/​0000105143 PubMedCrossRef
16.
Zurück zum Zitat Clough-Gorr KM, Thwin SS, Bosco JL, Silliman RA, Buist DS, Pawloski PA, Quinn VP, Prout MN (2013) Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up. Cancer 119(8):1478–1485. doi:10.1002/cncr.27914 PubMedCrossRef Clough-Gorr KM, Thwin SS, Bosco JL, Silliman RA, Buist DS, Pawloski PA, Quinn VP, Prout MN (2013) Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up. Cancer 119(8):1478–1485. doi:10.​1002/​cncr.​27914 PubMedCrossRef
17.
Zurück zum Zitat Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP (2011) Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomark Prev 20(10):2120–2126. doi:10.1158/1055-9965.EPI-11-0348 CrossRef Haque R, Yood MU, Geiger AM, Kamineni A, Avila CC, Shi J, Silliman RA, Quinn VP (2011) Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomark Prev 20(10):2120–2126. doi:10.​1158/​1055-9965.​EPI-11-0348 CrossRef
18.
Zurück zum Zitat Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TS (2013) Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc 61(6):888–895. doi:10.1111/jgs.12269 PubMedCrossRef Pawloski PA, Geiger AM, Haque R, Kamineni A, Fouayzi H, Ogarek J, Petersen HV, Bosco JL, Thwin SS, Silliman RA, Field TS (2013) Fracture risk in older, long-term survivors of early-stage breast cancer. J Am Geriatr Soc 61(6):888–895. doi:10.​1111/​jgs.​12269 PubMedCrossRef
19.
Zurück zum Zitat Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM (2005) Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr 35:3–11. doi:10.1093/jncimonographs/lgi032 PubMedCrossRef Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM (2005) Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr 35:3–11. doi:10.​1093/​jncimonographs/​lgi032 PubMedCrossRef
20.
Zurück zum Zitat Thwin SS, Clough-Gorr KM, McCarty MC, Lash TL, Alford SH, Buist DS, Enger SM, Field TS, Frost F, Wei F, Silliman RA (2007) Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study. BMC Med Res Methodol 7:23PubMedCentralPubMedCrossRef Thwin SS, Clough-Gorr KM, McCarty MC, Lash TL, Alford SH, Buist DS, Enger SM, Field TS, Frost F, Wei F, Silliman RA (2007) Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study. BMC Med Res Methodol 7:23PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
22.
Zurück zum Zitat Steenland K, Bray I, Greenland S, Boffetta P (2000) Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomark Prev 9(9):895–903 Steenland K, Bray I, Greenland S, Boffetta P (2000) Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies. Cancer Epidemiol Biomark Prev 9(9):895–903
23.
Zurück zum Zitat Greenland S, Robins JM (1991) Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 2:244–251PubMedCrossRef Greenland S, Robins JM (1991) Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 2:244–251PubMedCrossRef
24.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013) SEER Cancer Statistics Review, 1975–2010, based on November 2012 SEER data submission, posted to the SEER web site, April 2013 edn., Bethesda, MD Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013) SEER Cancer Statistics Review, 1975–2010, based on November 2012 SEER data submission, posted to the SEER web site, April 2013 edn., Bethesda, MD
26.
Zurück zum Zitat Maurea N, Coppola C, Ragone G, Frasci G, Bonelli A, Romano C, Iaffaioli RV (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med 11(12):861–868. doi:10.2459/JCM.0b013e328336b4c1 CrossRef Maurea N, Coppola C, Ragone G, Frasci G, Bonelli A, Romano C, Iaffaioli RV (2010) Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy. J Cardiovasc Med 11(12):861–868. doi:10.​2459/​JCM.​0b013e328336b4c1​ CrossRef
27.
Zurück zum Zitat Bradbury BD, Lash TL, Kaye JA, Jick SS (2005) Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer 103(6):1114–1121. doi:10.1002/cncr.20900 PubMedCrossRef Bradbury BD, Lash TL, Kaye JA, Jick SS (2005) Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer 103(6):1114–1121. doi:10.​1002/​cncr.​20900 PubMedCrossRef
28.
Zurück zum Zitat Deimling GT, Sterns S, Bowman KF, Kahana B (2005) The health of older-adult, long-term cancer survivors. Cancer Nurs 28(6):415–424PubMedCrossRef Deimling GT, Sterns S, Bowman KF, Kahana B (2005) The health of older-adult, long-term cancer survivors. Cancer Nurs 28(6):415–424PubMedCrossRef
29.
Metadaten
Titel
Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer
verfasst von
Timothy L. Lash
Soe Soe Thwin
Marianne Ulcickas Yood
Ann M. Geiger
Jaclyn Bosco
Virginia P. Quinn
Terry S. Field
Pamala A. Pawloski
Rebecca A. Silliman
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2885-y

Weitere Artikel der Ausgabe 3/2014

Breast Cancer Research and Treatment 3/2014 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.